Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
IQE
0.00%
1.1¢
Intueri Education Group Limited (in Liquidation)
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IQE | Ann: Intueri Education Group Limited (in Liquidation) -Delisting | 09/10/17 | 0 | 769 | |||
|
|||||||
IQE | Ann: Delisting of IQE shares from NZX | 09/10/17 | 0 | 870 | |||
|
|||||||
IQE | Ann: Market Announcement - Intueri Education Group Ltd | 12/09/17 | 0 | 720 | |||
|
|||||||
IQE | Ann: IQE Appointment of Liquidators to Intueri NZ entities | 01/09/17 | 0 | 744 | |||
|
|||||||
IQE | IQE Possible class action | 14/08/17 | 0 | 765 | |||
|
|||||||
IQE | Ann: IQE Completion of Sale of Intueri Schools | 03/07/17 | 0 | 703 | |||
|
|||||||
IQE | Ann: IQE Sale of Intueri New Zealand Schools | 16/06/17 | 0 | 752 | |||
|
|||||||
IQE | Ann: IQE Intueri Annual General Meeting | 14/06/17 | 0 | 787 | |||
|
See All Discussions